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Abstract
The Genetic Analysis Workshop 13 simulated data aimed to mimic the major features of the real
Framingham Heart Study data that formed Problem 1, but under a known inheritance model and
with 100 replicates, so as to allow evaluation of the statistical properties of various methods. The
pedigrees used were the 330 real pedigree structures (comprising 4692 individuals) with some
minor changes to protect confidentiality. Fifty trait genes and 399 microsatellite markers were
simulated by gene dropping on 22 autosomal chromosomes. Assuming random ascertainment of
families, a system of eight longitudinal quantitative traits (designed to be similar to those in the real
data) was generated with a wide range of heritabilities, including some pleiotropic and interactive
effects. Genes could affect either the baseline level or the rate of change of the phenotype.
Hypertension diagnosis and treatment were simulated with treatment availability, compliance, and
efficacy depending on calendar year. Nongenetic traits of smoking and alcohol were generated as
covariates for other traits. Death was simulated as a hazard rate depending upon age, sex, smoking,
cholesterol, and systolic blood pressure.
After the complete data were simulated, missing data indicators were generated based on logistic
models fitted to the real data, involving the subject's history of previous missing values, together
with that of their spouses, parents, siblings, and offspring, as well as marital status, only-child
indicators, current value at certain simulated traits, and the data collection pattern on the cohort
into which each subject was ascertained.
Background
Our goal in simulating data for Genetic Analysis Work-
shop 13 (GAW13) was to provide a data set with the basic
features of the real data [1], a set of families from the
Framingham Heart Study (FHS) [2], but under a known
"true" inheritance model. The Framingham study has a
number of unique features, but those we focused on rep-
licating in our simulated set were the longitudinal collec-
tion over many years of several related traits on a large set
of pedigrees and the availability of a complete genome
screen with microsatellite markers. There has been a rap-
idly growing statistical literature on the analysis of
dependent data, including longitudinal data, but seldom
have genetic analyses addressed simultaneously the com-
plexities of dependencies both within individuals over
time and between individuals within pedigrees. Longitu-
dinal data pose additional challenges with potentially
informative missingness. This simulated set allows studies
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of false-positive rates and power for methods that might
be applicable to the real data. It was our intention to
encourage comparisons between results from the real and
simulated sets, in the hope that some groups would find
both sets useful in developing new methods.
To facilitate the use of both real and simulated data
together, the simulated data set contains variables with
the same names and in the same format as the real data.
As with the real data, the simulated data contains meas-
ures of height (HT), weight (WT), high density lipopro-
tein (HDL), total cholesterol (CHOL), triglycerides (TG),
glucose (GLUC), systolic blood pressure (SBP), hyperten-
sion diagnosis and treatment (T), cigarettes smoked per
day (SMK), and quantity of alcohol consumed per week
(DRINK). These variables were simulated longitudinally
on two cohorts drawn from 330 pedigrees containing
4692 individuals, with data collection on each cohort
starting about 30 years apart. The first cohort was exam-
ined 21 times at 2-year intervals, while the second was
examined 5 times with an 8-year interval between the first
two exams and 4-year intervals between subsequent
exams. A missing data pattern was simulated to mimic
that seen in the real data. To avoid any potential confu-
sion with the real data, the placement of some individuals
within some pedigrees was changed and all the sexes were
randomized.
Underlying the phenotype simulation, we simulated 449
genetic loci on 22 autosomal chromosomes via random
gene drop. These included 399 microsatellite markers and
50 trait loci. We used a sex-specific map — another first
for a GAW simulation — and the allele frequencies of the
markers provided for the Framingham Heart Study data.
The trait loci were randomly placed, but some chromo-
somes were excluded from having loci placed on them, so
false-positive rates could be assessed. The 50 trait genes
fed into a complex model (Figure 1), with some genes
affecting the "baseline" trait value, and others affecting
change in the trait over time. Some genes directly affect
only one trait; others affect several. Some effects of these
trait loci are large and easy to detect, some are smaller and
more difficult to detect, and some are so small we expect
them to be impossible to detect in a single replicate. We
included genes of miniscule effect both to add a degree of
realism to the simulation and in the hope that our expec-
tation will be proven wrong.
Despite the complexity in this model, we are under no
illusion that we met the impossible goal of exactly model-
ling the unknown biological mechanisms underlying
these traits. Our primary concern was to provide a data set
with a variety of different types of effects. These effects are
designed to help us understand what types of genetic
effects can and cannot be detected in a real data set like
that collected in the Framingham study. In deciding what
effects to include, we gave consideration to the correla-
tions in the real data and the advice of biologists. We
placed some limits on the types of models we considered:
for reasons of limited human and computer time, we
excluded any models that contained feedback loops,
which almost certainly exist between some of these traits
in reality: it is possible that increasing cholesterol levels
contributes to weight gain, which in turn contributes to
higher cholesterol levels, but this type of interaction was
not included. Similarly, we only allowed the genetic
effects to interact with each other and the environmental
effects additively or multiplicatively: we felt it was more
important to focus our time on the longitudinal aspects of
the model. This simulated data set is designed to aid in the
testing of methods, not to illustrate the workings of the
human body.
Although our simulation is far less complex than reality,
there is still much complexity in the model. We have inter-
acting environmental variables: smoking is affected by
parental smoking and birth year, while drinking is
affected by smoking and birth year. Both the criteria for
hypertension treatment and the treatment itself change
with time. There are both direct sex effects and sex-moder-
ated effects. The 50 loci we included represent nearly an
order of magnitude more than have been included in pre-
vious GAW simulations. Of the eight simulated traits that
were directly affected by trait loci, weight had the smallest
number directly affecting it, with three, and glucose the
most, with 16. Some trait loci had direct effect on two or
three traits. When indirect effects are considered as well,
the picture is even more complex: all 50 trait loci have an
effect, direct or indirect, on hypertension diagnosis and
DBP. We expect that this data set contains far more com-
plexity than can be detected, even if all 100 simulated rep-
licates of the data are analyzed simultaneously. In this
respect, we believe that this simulated set does mirror
reality.
Methods
For this simulation, we broke the process into several
parts. First, we constructed pedigrees based on those in the
Framingham study, along with simulated birth years. This
was followed by simulation of genotypes via random gene
drop. These genotypes and the pedigrees were then fed
into a program to generate the longitudinal data. Finally,
a missing data program was run to determine which vari-
able values were observed, including whether each indi-
vidual was a member of Cohort 1, Cohort 2, or neither.
Pedigree structures
The pedigrees and individual birth years were the same for
all 100 replicates of the simulated data. We took the ped-
igrees provided by the Framingham Heart Study for GAWBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S3
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and randomized the sexes. In an effort to further obscure
any connection between the real and simulated pedigrees,
in a few of the larger pedigrees, we deleted an individual
from one sibship and added an individual to another sib-
ship within the same pedigree, thus maintaining the same
sample size. The sample contained 4692 individuals in
330 families containing 7 to 84 people. Two of the fami-
lies contained marriage loops. Because the ascertainment
and missing data part of the simulation contained a ran-
dom component, the number of individuals genotyped
and phenotyped differed slightly between replicates: in
the first replicate, which was the one GAW participants
using only a single replicate were advised to use, 1720
individuals were genotyped and 2860 had some pheno-
type information available. We approximated the ages in
the real data by assuming the first visit for the "original"
cohort occurred in 1948 and the first visit for the "off-
spring" cohort occurred in 1972. We used these approxi-
mate ages to obtain distributions for age differences
between mother and first child for sibships of different
sizes, between set of sibs for sibships of different sizes, and
for husband-wife age differences. We discarded some out-
liers from these distributions and then used them to ran-
domly assign ages to the pedigrees by selecting a reference
individual for each pedigree in a sibship without off-
spring, assigning that individual a birth year between
1937 and 1942 (uniform distribution), and spanning the
pedigree by drawing randomly, with replacement, from
the age difference distributions. If all individuals in a ped-
igree were born after 1952, or at least one individual was
born after 1935 in a sibship without offspring, then ran-
dom age assignment was repeated until obtaining one
Diagram of relationships between simulated traits and genes Figure 1
Diagram of relationships between simulated traits and genes. Arrows indicate causal relationships between traits. 
Most correlations are positive, but a "-" indicates a negative correlation. An "*" and trait name next to an arrow indicates that 
the relationship is mediated by the named trait.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S3
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that met the requirements. Four pedigrees failed to have
ages assigned after 500 iterations of the process, so we
took one of the random age assignments for each of these
four pedigrees and modified it so that it passed the rejec-
Table 1: Genome placement, traits affected, and allele frequencies for all model trait loci
Locus Name Haldane Map Position (cM) Allele Frequencies
Chrom. Male Female Sex Ave Trait(s) affected A B C D
Gb1 5 63.07 104.37 80.41 HT 0.40 0.30 0.30
Gb2 7 128.43 248.54 184.89 HT 0.70 0.30
Gb3 13 95.89 145.21 120.10 HT 0.50 0.50
Gb4 13 39.71 41.89 41.75 HT 0.85 0.15
Gb5 9 131.04 214.88 169.62 HT 0.70 0.30
Gb6 7 27.20 31.23 28.69 HT 0.90 0.10
Gb7 5 118.23 207.92 157.98 HT 0.50 0.30 0.20
Gb8 21 4.47 33.95 18.25 HT 0.20 0.80
Gb9 9 38.69 24.72 30.50 HT 0.50 0.50
Gb10 7 92.04 159.96 123.53 HT 0.50 0.30 0.20
Gb11 13 57.29 83.34 70.53 WT 0.40 0.30 0.20 0.10
Gb12 9 18.12 4.66 10.83 HDL, TG, GLUC 0.65 0.35
Gb13 9 65.43 105.28 82.76 HDL, TG, GLUC 0.50 0.30 0.10 0.10
Gb14 1 199.01 398.38 293.26 HDL, TG, GLUC 0.75 0.25
Gb15 21 34.93 66.97 49.65 HDL, TG, GLUC 0.45 0.35 0.20
Gb16 3 88.06 120.35 102.17 HDL, TG, GLUC 0.50 0.40 0.10
Gb17 1 63.06 143.18 100.73 HDL, TG, GLUC 0.40 0.30 0.30
Gb18 17 57.79 81.79 67.77 HDL, TG, GLUC 0.60 0.30 0.10
Gb19 17 44.99 18.83 31.14 HDL, TG, GLUC 0.70 0.20 0.10
Gb20 17 49.99 27.83 38.14 HDL 0.30 0.40 0.30
Gb21 11 47.00 42.93 45.14 HDL 0.80 0.20
Gb22 5 8.64 2.20 5.33 HDL 0.20 0.40 0.40
Gb23 19 107.83 128.20 114.52 TG 0.85 0.15
Gb24 15 50.70 37.69 43.84 TG 0.90 0.10
Gb25 1 108.85 218.67 160.75 TG 0.20 0.55 0.25
Gb26 7 15.77 5.57 10.35 GLUC 0.70 0.20 0.10
Gb27 3 48.64 36.61 41.84 GLUC 0.80 0.20
Gb28 3 144.79 222.50 180.81 GLUC 0.25 0.25 0.50
Gb29 17 55.98 73.57 62.89 GLUC 0.55 0.45
Gb30 11 60.03 73.31 66.19 CHOL 0.45 0.35 0.20
Gb31 1 114.67 238.40 172.93 CHOL 0.15 0.25 0.60
Gb32 15 107.90 146.91 124.76 CHOL 0.50 0.45 0.05
Gb33 3 49.10 43.87 45.53 CHOL 0.50 0.40 0.10
Gb34 5 126.71 237.14 176.08 SBP 0.70 0.30
Gb35 13 65.67 104.81 85.16 SBP 0.50 0.50
Gb36 7 44.79 51.35 47.49 SBP 0.80 0.20
Gb37 21 10.68 49.64 29.13 DBP 0.85 0.15
Gb38 7 6.53 1.02 3.64 DBP 0.90 0.10
Gs1 11 43.06 39.41 41.44 WT 0.75 0.25
Gs2 7 58.03 68.69 62.69 WT 0.15 0.70 0.15
Gs3 5 13.75 3.45 8.46 TG, GLUC 0.40 0.45 0.15
Gs4 9 53.45 66.06 58.02 TG, GLUC 0.30 0.30 0.40
Gs5 7 97.27 169.70 130.84 TG, GLUC 0.70 0.15 0.15
Gs6 21 2.26 17.52 9.04 TG, GLUC 0.60 0.30 0.10
Gs7 7 106.64 190.62 145.89 CHOL 0.60 0.30 0.10
Gs8 15 63.90 87.03 74.29 CHOL 0.40 0.30 0.30
Gs9 21 1.34 3.45 1.92 CHOL (FEMALE) 0.50 0.40 0.10
Gs10 21 41.26 68.75 53.59 SBP, DBP 0.70 0.30
Gs11 15 9.52 0.00 4.49 SBP, DBP 0.75 0.25
Gs12 21 10.95 50.03 29.46 SBP, DBP 0.80 0.20BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S3
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Table 2: Effects of genotypes at trait loci.
Locus Name Trait affected Effect of genotype on trait:
Variance Mean AA AB BB AC BC CC AD BD CD DD
Gb1 HT 0.4 0 -0.907 -0.475 -0.043 0.173 0.605 1.252
Gb2 HT 0.2 0 -0.312 0.088 1.287
Gb3 HT 0.1 0 -0.447 0.000 0.447
Gb4 HT 0.05 0 -0.071 0.077 1.411
Gb5 HT 0.02 0 -0.131 0.087 0.306
Gb6 HT 0.02 0 -0.067 0.267 0.600
Gb7 HT 0.02 0 -0.072 -0.046 -0.020 -0.059 0.186 0.574
Gb8 HT 0.01 0 -0.426 -0.053 0.053
Gb9 HT 0.01 0 -0.169 0.074 0.020
Gb10 HT 0.01 0 -0.038 -0.028 -0.018 -0.033 0.063 0.466
Gb11 WT 0.4 0 -0.564 -0.404 -0.163 1.442 -0.243 -0.002 1.041 0.238 0.640 2.245
Gb12 HDL 0.2 0 -0.464 0.199 0.862
GLUC 0.05 0 0.232 -0.099 -0.431
TG 0.1 0 0.328 -0.141 -0.609
Gb13 HDL 0.1 0 -0.195 0.125 0.444 -0.163 0.189 2.106 -0.259 -0.003 -0.514 -0.834
GLUC 0.1 0 0.243 0.018 -0.545 -0.207 -0.657 -0.770 0.356 0.131 -0.095 0.918
TG 0.1 0 0.191 -0.123 -0.438 -0.186 -0.312 -0.501 0.506 0.065 -0.060 1.766
Gb14 HDL 0.05 0 -0.141 0.085 0.761
GLUC 0.15 0 0.340 -0.416 -0.567
TG 0.2 0 0.390 -0.461 -0.745
Gb15 HDL 0.02 0 -0.156 -0.006 0.144 -0.081 0.069 0.518
GLUC 0.2 0 0.736 -0.095 -0.649 0.182 -0.372 -0.511
TG 0.1 0 0.242 -0.161 -0.565 0.444 0.040 -0.363
Gb16 HDL 0.02 0 -0.180 0.049 0.201 -0.104 -0.027 0.582
GLUC 0.05 0 0.140 0.004 -0.403 0.412 -0.132 -0.268
TG 0.02 0 0.213 -0.036 -0.201 -0.118 0.047 0.130
Gb17 HDL 0.01 0 0.066 -0.060 -0.186 0.129 0.003 -0.123
GLUC 0.05 0 -0.237 -0.183 -0.022 0.032 0.139 0.569
TG 0.05 0 -0.339 -0.143 -0.025 0.053 0.211 0.446
Gb18 HDL 0.005 0 0.026 -0.012 -0.199 0.063 0.101 -0.086
GLUC 0.01 0 -0.082 -0.004 0.114 0.036 0.153 0.699
TG 0.01 0 -0.060 0.001 0.032 -0.029 0.245 0.702
Gb19 HDL 0.005 0 0.045 -0.092 -0.147 0.073 -0.010 -0.037
GLUC 0.01 0 -0.078 0.088 0.155 -0.045 0.254 0.321
TG 0.005 0 -0.033 -0.005 0.108 -0.005 0.249 0.390
Gb20 HDL 0.15 0 -0.601 -0.204 0.589 -0.403 0.192 0.391
Gb21 HDL 0.05 0 -0.166 0.279 0.428
Gb22 HDL 0.01 0 -0.142 -0.118 -0.046 -0.094 0.122 0.050
Gb23 TG 0.01 0 -0.044 0.077 0.561
Gb24 TG 0.005 0 -0.018 0.046 0.659
Gb25 TG 0.005 0 -0.221 -0.028 0.049 -0.105 0.010 0.126
Gb26 GLUC 0.1 0 -0.212 0.272 0.175 -0.115 0.369 2.208
Gb27 GLUC 0.05 0 -0.150 0.207 0.741
Gb28 GLUC 0.02 0 -0.237 -0.065 0.108 -0.151 0.022 0.194
Gb29 GLUC 0.01 0 -0.128 0.014 0.156
Gb30 CHOL 0.2 0 -0.611 0.240 0.362 -0.489 0.483 0.605
Gb31 CHOL 0.15 0 -0.825 -0.436 -0.047 -0.630 0.148 0.342
Gb32 CHOL 0.1 0 -0.276 -0.140 0.404 0.268 0.676 2.444
Gb33 CHOL 0.05 0 -0.117 -0.053 0.012 -0.085 0.528 1.496
Gb34 SBP 0.25 0 -0.463 0.309 1.080
Gb35 SBP 0.15 0 -0.353 -0.151 0.655
Gb36 SBP 0.1 0 -0.236 0.406 0.535
Gb37 DBP 0.4 0 -0.376 0.877 2.129
Gb38 DBP 0.1 0 -0.118 0.397 2.456
Gs1 WT 0.5 0 -0.445 0.267 2.405
Gs2 WT 0.4 0 -1.146 -0.652 0.334 -0.159 0.828 2.308
Gs3 TG 0.00408 0.058 0 0.05 0.1 0.02 0.2 0.4BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S3
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tion criteria. It was because of the complexity we encoun-
tered in this age assignment process and the limited time
available that we decided to use the same ages for all 100
replicates.
Marker and trait genotypes
The genotype simulation was done with the Genedrop
program in the PANGAEA: Morgan package
http:www.stat.washington.edu/thompson/Genepi/pan
gaea.shtml. The simulated markers are based on those
available in the real data, which was genotyped using the
Marshfield mapping panel 8A. We used the sex-specific
Haldane map distances obtained by converting the maker
positions found at the Marshfield web site http://
www.marshfieldclinic.org/research/genetics/ from
Kosambi to Haldane centimorgans. The allele frequencies
used in the simulation were those provided to us by the
Framingham Heart Study group. We assumed Hardy-
Weinberg and linkage equilibrium between all loci, both
trait and marker. The 50 simulated trait genes were ran-
domly placed on the odd-numbered chromosomes (Table
1), leaving the even-numbered chromosomes available
for false-positive studies. Initially, we simulated the trait
genes with 20 equally frequent alleles to give us flexibility
in assigning those genes to different traits with different
allele frequencies. These 20 alleles were reduced to two,
three, or four alleles when we generated the trait values.
To generate the longitudinal data, we simulated data
points for each individual in every year, from the time
they were 20 until they reach 100. In all the trait models
we used here, we restricted genes to be one of two types:
"baseline" genes have a constant absolute effect on the
trait value over time, while "slope" genes have a changing
effect over time. In terms of percentage variance contribu-
tion to the trait, baseline genes will tend to have a decreas-
ing effect with time, while slope genes will have an
increasing effect. The numerical effects of each genotype at
each locus are given in Table 2. Note that the variance
given for each locus is the absolute variance for that locus
rather than the proportional variance contribution: we
include these numbers as a guide for judging the relative
importance of each locus within a trait. Although the trait
model itself is complex (Figure 1), it has a flow to it, and
we cover the simulation of the trait values in that order.
The genotype simulation did not allow for any pedigree or
genotyping errors and treated the map function as cor-
rectly specified. Likewise in what follows, no errors were
simulated in the phenotype data, other than missing data.
Phenotypes
Height
Height (HT) is a "simple oligogenic" trait, in that all
effects are additive and there is no time dependence other
than random noise. The two sexes s = (m, f) were given dif-
ferent means and variances: we used the values from the
real data: µHT (m) = 68.13 in, µHT (f) = 62.57 in, σHT (m) =
3.02 in, σHT (f) = 2.70 in. Ten loci contribute to this trait,
Gb1,...,Gb10, with contributions to the sex-specific variance
of 40%, 20%, 10%, 5%, 2%, 2%, 2%, 1%, 1%, and 1%. In
addition, a random environmental effect (constant over
age) rHT contributes 14% of the sex-specific variance and
an age-specific random effect at age a  ("measurement
error"),  εHT(a), contributes 2% (both normally distrib-
uted). The formula used was:
where gbi is the effect of each individual's genotype at locus
Gbi (Table 2).
GLUC 5.36E-05 0.00059 -0.01 -0.002 0.002 0.004 0.01 0.03
Gs4 TG 0.00307 0.0633 0 0.01 0.02 0.1 0.12 0.15
GLUC 1.58E-05 -0.0003 -0.01 -0.003 -0.002 0 0.002 0.005
Gs5 TG 0.00036 0.0446 0.05 0.025 0 0.075 0.04 0.1
GLUC 8.77E-07 -7E-05 0 -0.001 -0.004 0.001 -5E-04 0.002
Gs6 TG 0.00119 0.09416 0.1 0.12 0.125 0.02 0.05 0
GLUC 6.34E-06 0.00045 0 0.002 0.0025 -0.002 -0.001 -0.02
Gs7 CHOL 0.36428 0.385 0 0.25 0.5 0.75 2 4
Gs8 CHOL 0.07582 0.291 0 0.1 0.3 0.25 0.5 1
Gs9 CHOL 0.03208 0.265 0.1 0.2 0.4 0.3 0.7 1
Gs10 SBP 0.12424 0.342 0 0.6 1
DBP 0.03016 0.138 0 0.2 0.6
Gs11 SBP 0.05859 0.1375 0 0.2 1
DBP 0.01934 0.10625 0 0.2 0.5
Gs12 SBP 0.01574 0.084 0 0.2 0.5
DBP 0.06054 0.184 0 0.5 0.6
Table 2: Effects of genotypes at trait loci. (Continued)
HT a s s s g r a HT HT bi
i
HT HT ,, () = () + () ++()
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Weight
We chose to make weight (WT) strongly dependent on
height via a BMI-like relationship, i.e., proportional to
height in meters squared. Weight was simulated in
pounds and height in inches, so some unit conversion was
required. Since a substantial number of studies have
reported localizations of genes influencing BMI in real
data, we wanted to provide a simulated data set in which
analysis of the simulated BMI could reasonably be
expected to localize some of the simulated trait loci. All
the loci that contribute to variation in height contribute
indirectly to variation in weight through the height varia-
ble. In addition, one locus contributes to baseline weight,
Gb11, and two contribute to a logarithmic change in
weight with age, Gs1 and Gs2.
WT(a) = (HT(a))2 (BWT + SWT log10(a)) + εWT (a),
where BWT = α(s) + 10(gb11 + rWT, fam + rWT,1),
SWT = 2+ 2 (gs1 + gs2 + rWT,2).
In this equation, we converted height to meters before
squaring it, and α(s) = 57 pounds/(meter)2 for males and
53 for females, rWT,fam a random effect for family, and rWT,1
and  rWT,2  time-constant normal deviates. The baseline
gene contributes 40% of the variance in sex-specific base-
line (BWT), family contributes 30% of sex-specific baseline
variance, and rWT1 contributes 30% of sex-specific baseline
variance. The slope genes contribute 50% and 40% of var-
iance to the multiplier (SWT), and rWT,2 contributes 10%.
εWT (a) was a N(0, √3) random number.
Smoking and drinking
Both smoking and drinking were simulated as "environ-
mental" variables (i.e., none of the simulated genes had a
direct effect on either variable). We used patterns
observed in the real data and from Johnson and Gerstein
[3] as guides in simulating these variables. We found that
the frequencies from Johnson and Gerstein did not pro-
duce the smoking and drinking rates observed in the real
data, so we followed the trends in that paper while
increasing the rates. We assumed that children of smokers
were twice as likely to smoke as children of non-smokers
and that smokers were 10% more likely to drink than
non-smokers, to produce a sex by cohort probability table
(Table 3). The probability of smoking depends on paren-
tal smoking. The probability of being a drinker depends
on whether an individual is a smoker. We sampled from
real-sample sex-specific distributions of drinks and ciga-
rettes to get the simulated quantities. For drinkers, this
sampled value was modified by height, so the quantity
consumed has a genetic component of variation through
height, but whether or not someone drinks does not. We
chose to make the quantity consumed dependent on
height, based on observing such a correlation in the real
data. The correlations with BMI and weight were not as
strong. Thus:
DRINK = dr ((HT/µHT (s)) + 1)/2,
where dr is the drink quantity (in grams per day), sampled
from the sex-specific distribution, HT is height (without
the measurement error term), and µHT(s) is the sex-spe-
cific mean height. Quantities for both smoking (SMK)
and drinking were fixed over time, but smokers have a
probability (a - 20)/1000 of quitting each year, so SMK(a)
denotes the current number of cigarettes smoked per day.
We also calculated pack-years (PY), assuming all smokers
started at age 18.
Table 3: Smoking and drinking probabilities.
Birth Year, Sex P(SMK| founder) P(SMK|no parents 
smoke)
P(SMK| 1+ parents 
smoke)
P(DRINK| SMK) P(DRINK| No 
SMK)
P(DRINK)
before 1930
male 0.600 0.375 0.750 0.490 0.390 0.450
female 0.200 0.167 0.333 0.180 0.080 0.100
1931–1940
male 0.600 0.375 0.750 0.540 0.440 0.500
female 0.300 0.231 0.462 0.220 0.120 0.150
1941–1945
male 0.600 0.375 0.750 0.540 0.440 0.500
female 0.350 0.259 0.519 0.265 0.165 0.200
1946–1950
male 0.500 0.333 0.667 0.550 0.450 0.500
female 0.350 0.259 0.519 0.265 0.165 0.200
1951–1955
male 0.450 0.310 0.621 0.655 0.555 0.600
female 0.350 0.259 0.519 0.315 0.215 0.250BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S3
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Lipids
High density lipoprotein (HDL), triglycerides (TG), and
glucose (GLUC) have eight baseline genes in common,
Gb12,...,Gb19, and TG  and GLUC have four slope genes,
Gs3,...,Gs6, in common as well. In addition, three baseline
genes (Gb20,...,Gb22) only contribute directly to HDL, three
(Gb23,...,Gb25) only contribute to TG, and four
(Gb26,...,Gb29) only contribute to GLUC. HDL and TG have
direct sex effects, and, in addition, the effects of Gs2,...,Gs6
on TG are mediated by sex via a menopause-like effect in
women. All three were simulated to correspond to the
measurements in units of mg/dl found in the real data.
Weight has an effect on TG and GLUC, drinking on HDL
and TG, and smoking on HDL. HDL and GLUC also have
a direct effect on TG. All these effects were consistent with
correlations seen in the real data. The equations used
were:
where  µHDL(s) = 41 mg/dl for men and 53 mg/dl for
women, σHDL(s) = 11 mg/dl for men and 12 mg/dl for
women,
 is the baseline DRINK effect on HDL, where WT(a) is
weight with no error,
 is the
baseline SMK(a) effect on HDL, and rHDL and εHDL(a) are
independent fixed (mean 0, variance 0.1) and age-varying
normal deviates, respectively. The genetic effects on HDL,
gHbi, are given in Table 2. While HDL has no slope term,
the presence of weight in the drinking term and people
quitting smoking will cause some age dependence.
Both GLUC and TG have exponential slope terms, but TG
also has a "menopause effect" in the slope term.
where
 is the glucose baseline term, with gGbi the effect of the gen-
otype at locus Gbi on GLUC (Table 2), WT(a) the weight
without error, µWT,s the sex-specific mean weight (176.03
pounds for men, 144.12 for women), and rGLUC,1 ~ N(0,
√0.1),
is the glucose slope term with gGsi the effect of the geno-
type at locus Gsi on GLUC and rGLUC,2 ~ N(0, √0.003). The
glucose slope term can be positive or negative and is small
in absolute value.
Triglycerides had baseline levels depending on DRINK,
HDL, GLUC, and WT, together with 11 genes, and a slope
that depended upon four genes, modified in females by a
complicated function of age and age at menopause, which
was also random:
where µ(s) = 75 mg/dl or 65 mg/dl and σ(s) = 25 mg/dl or
20 mg/dl for males or females, respectively, gTbi is the
effect of the genotype at locus Gbi on TG,
with µWT (s) = 160 pounds for males or 135 pounds for
females and εTG(a) ~ N(0, √0.1), and STG(GTsi,a) is a sex-
specific slope term as follows:
STG (GTsi, a, s = m) = (Σgsi + rs, TG)/20
where rs,TG ~ N(0, √0.1), and A = (a - 48 + rf), where rf ~
N(0, √2).
Cholesterol was simulated using a basic linear model,
with one sex-limited (female-only) slope gene:
CHOL(a) = BCHOL (TG, WT, Gbi) + (a - 20) SCHOL (s),
where
with rCHOL and εCHOL(a) both N(0, √0.1), and SCHOL(s) is
SCHOL(m) = (gs7 + gs8) × (1 + r) and SCHOL(f) = (gs7 + gs8 +
gs9) × (1 + r), with r ~ N(0, √0.1). The simulated units on
cholesterol were also mg/dl.
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Blood pressures
Untreated blood pressures were generated first in units of
mm Hg by the models:
SBP = 115 + BSBP (Gbi, WT, CHOL, SMK, GLUC) + (a - 20)
Σgsi
DBP = 65 + BDBP (Gbi, SBP) + ((a - 20)/2)Σgsi,
where
and
Both systolic and diastolic blood pressures were used in
determining hypertension diagnosis and treatment. How-
ever, only SBP was provided with the real data and the
simulated replicates, so, consequently, we kept the model
for DBP simpler. Hypertension treatment and diagnosis
were done separately. Hypertension was diagnosed if SBP
> 140 mm Hg or DBP > 90 mm Hg for 2 years in a row,
and once the diagnosis was made, it stuck. Hypertension
thresholds remained constant, but both the thresholds for
treatment and the efficacy of the treatments available
changed with time. Before 1960 no treatment was availa-
ble. From 1960 through 1975, there is a 50% chance (pre-
scription + compliance) of drug treatment if DBP rises
above 95. After the initial year of eligibility, there is a 90%
chance that an individual remains in the same treatment
class. This first treatment lowers SBP by 10 + N(0, √2) and
DBP by 7 + N(0, √1.5). Between 1976 and 1985, this drug
treatment remains available and, in addition, we add an
"exercise" treatment which those with DBP > 90 have a
50% chance of getting and a 90% chance of remaining in
the same treatment class after the initial year of eligibility.
The "exercise" treatment lowers SBP by 5 + N(0,1) and
DBP by 3 + N(0, √0.5). In 1986 and after, the first drug
treatment is replaced by a treatment with a 75% chance of
being administered to those with SBP > 150 or DBP > 95.
After the initial year of eligibility, there is a 95% chance of
remaining in the treated class, and those untreated have a
50% chance of switching to the treated class. This treat-
ment lowers SBP by 20 + N(0, √2) and DBP by 12 + N(0,
√1.5).
Death
Each person had an exponentially increasing probability
of dying each year:
δ(a) = 10αa (1 + (PY + SMK)/50 + (e(SBP-140)/10 - 1)/1000 +
max (CHOL - R(s),0)/100),
where α = 5 × 10-7, PY is pack-years, and R(s) is a sex-spe-
cific risk factor of 200 if male and 230 if female. However,
we placed the restriction that no person could die before
their youngest child was born. If an individual was simu-
lated with an age of death before the birth of their young-
est child, we increased the age of death to their age when
their youngest child was born.
Missing data simulation
The missing data pattern in the simulated data set was
simulated to resemble the missing data pattern in the real
data. In the real data, each visit had a planned subset of
the measurements that were to be taken. For each visit in
the simulated data, only the planned measurements for
that visit are included. A visit is considered to be complete
if all the planned measurements were taken.
In the real data, for each visit a subject may have none,
some, or all of the planned measurements missing. Only
visits with all the planned measurements missing were
used to determine the missing data patterns for the simu-
lated data sets. In the simulated data set, a visit is either
entirely missing or is complete.
The missing data patterns were summarized into three
variables, Hij as predictors of missingness Mij for subject i
on visit j: an indicator of the previous visit being missing;
an indicator of the visit two time periods ago being miss-
ing; and the proportion of possible visits that are missing.
The pattern of missing data for an individual includes all
three of these variables. The pattern of missing data for a
spouse includes the indicator variables for the last two vis-
its. For parent, and sibling history, only the percentage of
missing observations is used.
For each cohort, a logistic model was used to predict the
probability of a visit being missing given the subject's
missing data pattern, the missing data pattern of first
degree relatives, the missing data pattern of the spouse,
the measurements at the last nonmissing visit, marital sta-
tus, being an only child, and visit number. Observations
after time of death were not included in the model
because these are obviously missing.
For the initial cohort, the previous missing data pattern of
the subject,  , where 
denotes the proportion of missing values up to and
including visit j, and corresponding values for the sub-
ject's spouse (sp), and the subject's siblings (sib) were pre-
dictors. Marital status (MSij), being an only child (OCi),
cholesterol (CHOLij), weight (WTij), and visit number (j)
were also predictors. The following logistic models were
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created for the original cohort based on the real data (the
specific coefficients are listed in Table 4):
1. P(Mij| Mi,j-1, CHOLij, WTij, OCi, MSij, j)
2. P(Mij| Mi,j-1, Msp,j, HSPij,CHOLij, WTij, OCi, MSij, j)
3. P(Mij| Mi,j-1, Msib,j, CHOLij, WTij, OCi, MSij,j)
4. P(Mij| Mi,j-1, Msp,j j, Msib,j, CHOLij, WTij, OCi, MSij, j).
For the offspring cohort, the missing data pattern of the
subject, the subject's siblings, and the subject's parents
(Mpa = ( ,  )), together with indicators NApa for the
availability of parents in the data set, are predictors. Being
an only child, cholesterol, weight, and visit number were
also predictors. The following models were created for the
offspring cohort based on the real data:
5. P(Mij| Mi,j-1, Mpa, NAi, CHOLij, WTij, OCi, j)
6. P(Mij| Mi,j-1, Msib,j, NAi, Mpa, NAi, CHOLij, WTij, OCi, j).
The models were used to assign missing data patterns as
follows: A subject in the original cohort was selected at
random from a family and assigned a missing status for
Time 3 based on Model 1. (No observations were missing
for the first two visits.) The subject's first degree relatives
in the original cohort and spouses were then assigned
missing values given the already assigned data using Mod-
els 2–4. This continues until all subjects in the original
cohort were assigned a missing status for Visit 3. The proc-
ess is repeated for all other visits. Members of the off-
spring cohort were then assigned missing status. One of
the subjects of a sibship was selected at random and
assigned a missing value for Time 2 using Model 5. The
other siblings were then assigned missing values based on
the values of the already assigned siblings (Model 6). This
was done for all sibships in the offspring cohort. The proc-
ess was repeated for all the other times.
Genetic data were collected after a certain time point. Any
subject alive at the time when the genetic data were col-
lected had a probability of having genetic data based on
how many visits were not missing during the period
genetic data was collected. This is similar to what is seen
in the real data. In the simulated data set, a subject that
had no visits during the time of genetic data collection has
no marker data. A subject that has one visit has an 82%
chance of having genetic data, and a subject that has more
than one visit has an 85% chance of having genetic data.
Validation
The data were tested at several stages. As the raw trait data
were generated, we computed means and variances for
each trait and compared the simulated values to those in
the real data. We did many graphical comparisons of the
simulated data and the real FHS data, particularly with
trait vs. age plots. We compared correlation matrices in
the simulated data to those in the real data that we were
attempting to mimic. We ran linkage detection programs
to confirm that we could detect some of the trait genes we
simulated. Unfortunately, given the very tight time con-
straints, we were not able to check every part of the simu-
lation to the degree we would have liked.
Despite our best attempts to check all aspects of the simu-
lation, one serious bug escaped our notice and was
detected by Dr. Martin Tobin, affecting the part of the
missing data simulation concerning hypertension treat-
ment. This invalidated the data for the purpose of address-
ing the important question of how to deal with this
confounder, but did not affect the genetics of the problem
at all. A corrected version of the entire data set was pro-
vided to all GAW participants within a month of discovery
Table 4: Logistic regression coefficients for the missing data model.
Model αA Mi,j-1 Mi,j-2 Msp,j Msp,j-1 Msp,j-2 NAmo NAfa CHOLij WTij OCi MSij Visit (j)
1 -3.88 2.390 1.58 1.06 -0.005 0.003 0.093 0.297 0.0256
2 -4.36 2.650 1.85 0.86 3.83 -1.42 -1.13 -0.005 0.003 0.121 0.770 0.0213
3 -3.87 2.380 1.58 1.06 -0.010 -0.005 0.003 0.092 0.297 0.0256
4 -4.35 2.650 1.85 0.86 3.82 -1.14 -1.13 0.054 -0.005 0.003 0.120 0.770 0.0214
5 -1.52 0.919 1.80 0.87 0.88 -0.18 -0.41 -0.005 0.003 0.224 -0.4510
6 -1.71 0.903 1.74 1.710 0.64 0.73 -0.17 -0.31 -0.005 0.003 -0.4490
Aα, intercept; Mij, indicator for subject i's visit j being missing (with i replaced by sp, mo, fa, sib for spouse, mother, father, and sib respectively);  , 
average missingness proportion for subject i up to and including visit j (if the second subscript is omitted, the average is taken over the entire 
history); MS, marital status; NA, indicator for parents' being not available in the data set; OC, only child; CHOL, cholesterol; WT, weight.
Mij , − 1 Msib Mmo Mfa
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of the problem. The authors apologize for any inconven-
ience this may have caused.
Discussion
In creating this simulated data set, we intended to provide
a data set that would facilitate the development of statisti-
cal methods for analyzing longitudinal data. This creation
involved making a series of compromises — choices
about how to model reality and what effects to include
given the limited time available. We learned much in sim-
ulating this set, and, if we were to start over now and had
the same amount of time available, we would make a
number of choices slightly differently. Overall, however,
we are pleased with the results of our simulation, and we
think that having the simulation tightly linked to the real
data set greatly increases the value of the simulation.
The simulators and simulation oversight committee
agreed that it was of primary importance that the simula-
tion reflect the longitudinal nature of the real data and
include some informative missing data patterns. These
areas have not been extensively studied in the context of
genetic analysis and seem ripe with potential. Many traits
have values that change as the body ages, and the contri-
bution of such traits to complex genetic diseases is likely
to be important. The missing data patterns included
familial missing data patterns and measured covariate
effects, neither of which included direct genetic influ-
ences. In addition, death also induces an informative
missing data pattern with a number of indirect genetic
influences on this pattern via SBP and cholesterol. Direct
genetic influences and hypertension treatment influences
on missing data patterns are something we would have
liked to include, but did not simply for lack of time: each
additional pattern must be carefully balanced to ensure
that enough data is not missing.
The trait model used in this simulation was among the
most complex ever used in a GAW simulation, but it still
falls short of reality and we had many ideas on improving
the model that we were unable to pursue. We considered
generating the longitudinal data under a stochastic proc-
ess, rather than the deterministic model with normally
distributed random variables that we used. Unfortunately,
we felt that writing a program to do this would take more
time than we had. We started out thinking in terms of
fairly simple models with genes influencing "baseline" or
"slope." There are many other ways to model the effects of
trait loci over time when one considers interactions and
higher-order effects. Fifty trait loci on eight traits were not
enough for all the effects that did occur to us. We would
have liked to have many other types of effects, and had
genes that influenced smoking, drinking, and play a direct
role in treatment effect and death. However, there was
some risk that we would lose sight of the longitudinal
data focus if we included too many different types of
effects.
Both the simulation and the genetic analysis of longitudi-
nal data include many challenges. No simulation can per-
fectly match the complexity of real data, but we think that
this simulation provides enough complexity to enable
GAW participants to examine many of these challenges.
We hope the results of analyses of this set provide answers
to some of these challenges.
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